Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...
In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...
Researchers identify GmRVE4d as a gene that delays soybean flowering and maturity by repressing GmPRR5a. This finding highlights GmRVE4d as a potential breeding target for improving soybean adaptation ...
Fintel on MSN
PDS Biotechnology Corporation updates corporate presentation detailing PDS0301 and PDS0101 programs
PDS Biotechnology Corporation updated its corporate presentation on October 20, 2026, highlighting progress in its drug development programs. Following a September 2026 financing led by Nant Capital, ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "White Biotechnology Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The global white biotechnology market research report ...
UDYOG targets pre-final and final-year BTech, MTech, and MSc students in biotechnology offering practical skills through ...
Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today ...
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
Nautilus Biotechnology, Inc. is currently listed on NASDAQ under NAUT. One share of NAUT stock can currently be purchased for approximately $3.24. Is Nautilus Biotechnology, Inc. listed on the NASDAQ ...
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, November 4 to provide a corporate update and discuss its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results